Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 234 (8%) | |
Anticipated shortage: | 20 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2019-02-24 | 2019-03-29 | 76729 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-24 | 2019-04-15 | 76726 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2019-02-24 | 2019-03-08 | 76723 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-02-24 | 2019-04-26 | 76720 |
APO-IBUPROFEN | 200MG | TABLET | Resolved | 2019-02-24 | 2020-04-01 | 76717 |
APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-24 | 2019-07-12 | 76714 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-21 | 2019-07-05 | 76585 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-21 | 2019-04-05 | 76582 |
APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2019-02-13 | 2019-04-22 | 75641 |
BACKUP PLAN ONESTEP | 1.5MG | TABLET | Resolved | 2019-02-13 | 2019-02-21 | 75635 |
APO-TERBINAFINE | 250MG | TABLET | Resolved | 2019-02-13 | 2020-08-10 | 75632 |
APO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-13 | 2019-03-07 | 75629 |
APO-RANITIDINE | 15MG | SOLUTION | Resolved | 2019-02-13 | 2019-04-05 | 75626 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2019-02-13 | 2019-03-30 | 75623 |
APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2019-02-13 | 2019-03-07 | 75620 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-13 | 2019-02-21 | 75617 |
APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-13 | 2019-07-12 | 75614 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-13 | 2019-07-05 | 75611 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2019-02-13 | 2019-04-22 | 75608 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2019-02-06 | 2019-06-24 | 74935 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 |